Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV is a research paper published in Clinical Infectious Diseases (2025). On theSindex it has a DataRank of 0.410. It has been cited 7 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0982
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institutes of Health
Grant: U01HL123336
National Institutes of Health
Grant: 1UG3HL164285
Clinical Coordinating Center
Grant: U01HL123339
Clinical Coordinating Center
Grant: 1U24HL164284
National Institute of Allergy and Infectious Diseases (NIAID
Grant: UM1 AI068636
ACTG Leadership and Operations Center
Grant: UM1 AI106701
Nutrition Obesity Research Center at Harvard
Grant: P30DK040561
NIAID NIH HHS
Grant: K24 AI157882
NIAID NIH HHS
Grant: UM1 AI068634
NIAID NIH HHS
Grant: P30 AI050410
NHLBI NIH HHS
Grant: UG3 HL164285
NIAID NIH HHS
Grant: R01 AI123001
NIAID NIH HHS
Grant: UM1 AI069424
NIAID NIH HHS
Grant: UM1 AI069412
NHLBI NIH HHS
Grant: U24 HL164284
ViiV Healthcare
Gilead Sciences
Kowa Pharmaceuticals America, Inc
Data Coordinating Center
ACTG Laboratory Center
Data Coordinating Center
Kowa Pharmaceuticals America, Inc
Gilead Sciences
ViiV Healthcare
ACTG Laboratory Center
FWCI
9.57
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals